Back to search
FDAFDA · Food and drugs·Recall number Z-1461-2017

L-Varlock Cage/Trial Implant Holder, Reference HD0060, Kisco International, France. Product Usage: The L-Varlock Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). L-Varlock Lumbar implants are to be used with autogenous bone graft and implanted via an open posterior approach. L-Varlock Lumbar implant is to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.

Published March 22, 2017 · Recall initiated: January 11, 2017

Summary

FDA records medical device Class II recall Z-1461-2017, published March 22, 2017 and initiated January 11, 2017. Recalling firm: Kiscomedica S.A.; Status: Terminated; Reported quantity: 13 units; Lot: Batch number: 15486. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Firm received a complaint of the tip holder breaking during use.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Kiscomedica S.A.
Distributor
Worldwide Distribution - US Nationwide in the states of MO and country of Switzerland.
Lot
Batch number: 15486
Risk classification
Class II
Area (FDA)
device
Country
France

Related recalls

Questions about this recall

Was L-Varlock Cage/Trial Implant Holder, Reference HD0060, Kisco International, France. Product Usage: The L-Varlock Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). L-Varlock Lumbar implants are to be used with autogenous bone graft and implanted via an open posterior approach. L-Varlock Lumbar implant is to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage. recalled?

Yes. FDA published recall Z-1461-2017 on March 22, 2017. Reported hazard: Firm received a complaint of the tip holder breaking during use.

What should I do if I have this product?

Voluntary: Firm initiated · Letter